Bay Area Tumor Institute CCOP

湾区肿瘤研究所 CCOP

• 批准号: 6938661
• 负责人: James Feusner
• 金额: $ 37.57万
• 依托单位: BAY AREA TUMOR INSTITUTE
• 依托单位国家: 美国
• 财政年份: 1993
• 资助国家: 美国
• 起止时间: 1993-06-25 至 2007-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6938661
• 关键词: African American; Asian Americans; Hispanic Americans; behavioral /social science research tag; cancer prevention; cancer rehabilitation /care; chemoprevention; clinical research; clinical trials; community health services; cooperative study; female; health services research tag; human subject; human therapy evaluation; low socioeconomic status; medical outreach /case finding; medical rehabilitation related tag; neoplasm /cancer; neoplasm /cancer therapy; oncology; patient oriented research; pediatric neoplasm /cancer; primary care physician

DESCRIPTION (provided by applicant): The Bay Area Tumor Institute Community Clinical Oncology Program (BATI-CCOP) is a consortium of seven community and county hospitals in the Greater Oakland, California, area. Since its creation in 1979 as a CGOP and its conversion to CCOP status in 1989, this consortium has continuously provided the community's cancer specialists, primary care physicians, and hospitals with an NCI-approved and funded clinical trials program. Integrating the goals of DHHS publication "Healthy People 2010" by targeting minority, low income and female populations in Alameda County and its main city, Oakland, the BATI-CCOP enables cancer patients and the general "at risk" population to participate in clinical and cancer control research of SWOG, NSABP, RTOG, and COG. Building on its achievements, the long-term objectives and specific aims of the BATI-CCOP include accrual to therapeutic trials at higher rates than comparable CCOP's, accrual of minority and pediatric patients at higher rates than all other CCOP's, aggressive cancer control recruitment and accrual exceeding NCI's cancer control research requirements, increased interaction with research bases, and continued fulfillment of NCI's "Terms of Cooperation." The CCOP will continue to accrue 100% of all eligible pediatric oncology patients in the region, accrue 50% of all eligible cancer patients at the county hospital, and achieve minority and female participation that will exceed 75% of the total CCOP accrual. The CCOP will also continue to exceed NCI mandates and remain the Bay Area leader in accrual to cancer prevention and control trials. The BATI-CCOP offers a successful long-term track record, an organized and committed medical community, experienced physician investigators, institutional and financial support from the Bay Area Tumor Institute, and unusual access to African American, Hispanic, Asian, pediatric, underserved, and female populations.

描述（由申请人提供）： 湾区肿瘤研究所社区临床肿瘤学计划 (BATI-CCOP) 是由大区七家社区和县医院组成的联盟 加利福尼亚州奥克兰地区。自 1979 年作为 CGOP 创建以来， 1989 年转换为 CCOP 地位后，该财团不断提供 社区的癌症专家、初级保健医生和医院 拥有 NCI 批准并资助的临床试验计划。整合 DHHS 出版物《健康人民 2010》的目标是针对少数族裔、低收入人群 阿拉米达县及其主要城市奥克兰的收入和女性人口， BATI-CCOP 使癌症患者和一般“高危”人群能够 参与SWOG、NSA​​BP、RTOG等临床和癌症控制研究 重心。立足于其成就、长期目标和具体目标 BATI-CCOP 的治疗试验应计率高于 类似的 CCOP，少数族裔和儿科患者的应计率更高 与所有其他 CCOP 相比，积极的癌症控制招募和累积 超出 NCI 的癌症控制研究要求，增加互动 拥有研究基地，并持续履行NCI的“条款” 合作。”CCOP 将继续为所有符合条件的儿科儿童提供 100% 的奖励 该地区的肿瘤患者占所有符合条件的癌症患者的 50% 县医院，并实现少数民族和女性的参与，这将 超过 CCOP 应计总额的 75%。 CCOP也将继续超过 NCI 要求并在癌症预防方面保持湾区领先地位 和对照试验。 BATI-CCOP 提供了成功的长期记录， 一个有组织且忠诚的医疗社区，经验丰富的医生 来自湾区肿瘤的研究人员、机构和财政支持 研究所，以及非裔美国人、西班牙裔、亚洲人、儿科、 服务不足和女性人口。